Group One Trading’s Minerva Neurosciences NERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,785
Closed -$9.2K 7686
2022
Q4
$9.2K Sell
5,785
-48
-0.8% -$208 ﹤0.01% 6061
2022
Q3
$54K Sell
5,833
-36
-0.6% -$213 ﹤0.01% 5346
2022
Q2
$19K Buy
+5,869
New +$24K ﹤0.01% 6329
2022
Q1
Sell
-1,349
Closed -$8.28K 8456
2021
Q4
$9K Sell
1,349
-3,902
-74% -$36.7K ﹤0.01% 7405
2021
Q3
$73K Buy
+5,251
New +$79K ﹤0.01% 6222
2021
Q1
Sell
-1,121
Closed -$28K 7870
2020
Q4
$21K Sell
1,121
-16,748
-94% -$422K ﹤0.01% 5500
2020
Q3
$455K Sell
17,869
-4,079
-19% -$110K ﹤0.01% 2926
2020
Q2
$634K Buy
21,948
+6,483
+42% +$380K ﹤0.01% 2435
2020
Q1
$745K Buy
15,465
+10,677
+223% +$644K 0.01% 1751
2019
Q4
$272K Buy
+4,788
New +$211K ﹤0.01% 2941
2019
Q2
Sell
-229
Closed -$11.5K 5239
2019
Q1
$14K Hold
229
﹤0.01% 4158
2018
Q4
$12K Hold
229
﹤0.01% 4201
2018
Q3
$23K Buy
229
+227
+11,350% +$17.1K ﹤0.01% 4344
2018
Q2
$0 Buy
+2
New +$121 ﹤0.01% 5335
2017
Q2
Sell
-175
Closed -$11.3K 4955
2017
Q1
$11K Buy
175
+62
+55% +$4.82K ﹤0.01% 4090
2016
Q4
$11K Sell
113
-12
-10% -$1.23K ﹤0.01% 3915
2016
Q3
$14K Buy
+125
New +$12.1K ﹤0.01% 3933

Other funds holding NERV

Group One Trading's NERV Position: Q1 2023 in Review

Group One Trading sold out of Minerva Neurosciences (NERV) in Q1 2023, closing a stake of 5,785 shares — an estimated $9.2K sold.

Group One Trading first reported a position in NERV in Q3 2016 and held it in 17 quarters. The position peaked at $745K in Q1 2020. 17 funds tracked by Wall St. Rank hold NERV as of Q1 2023.

  • Group One Trading reported no remaining Minerva Neurosciences position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 5,785 Minerva Neurosciences shares in Q1 2023, an estimated $9.2K.
  • Group One Trading first reported a position in Minerva Neurosciences in Q3 2016 and held it in 17 quarters.
  • Group One Trading's Minerva Neurosciences position peaked at $745K in Q1 2020.
  • 17 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.